Transcranial Magnetic Stimulators Market size was valued at US$ 1.58 Bn. in 2022 and the total revenue is expected to grow at 8.7% from 2022 to 2029, reaching nearly US$ 2.83 Bn. The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report Transcranial magnetic stimulation i.e. TMS is a magnetic process used to stimulate small areas of the brain. Various medical factors are influencing the growth of the market for the transcranial magnetic stimulator. Neurological disorders are the prominent cause of disability and death across the world currently. The upsurge in the patient suffering from Multiple Sclerosis, Cerebrovascular, Epilepsy, Alzheimer’s, and Parkinson’s, offer ample growth opportunities for the TMS market globally. The MMR report analyzes factors affecting the TMS market from both demand and supply side and further estimates market dynamics affecting the market during 2022-2029 i.e., drivers, restraints, challenges, and opportunities. In 2018, as per the ScienceDirect report, 5.8 million individuals in the United States were suffering from AD (Alzheimer's disease). Also, in the United States, as per study is found that every 65 seconds, somebody is diagnosed with Alzheimer's disease. As stated by the World Health Organization, in Europe proximate 10 million people are affected by dementia. The number of people suffering from dementia is likely to upsurge from 50 million in 2018 to 152 million by 2050. So, the growing prevalence of Alzheimer's disease along with dementia is likely to help TMS market growth. North America transcranial magnetic stimulators market was valued at US$ xx million in 2022 and is expected to reach a value of US$ xx million by 2029, with a CAGR of xx.20% during the forecast period. Major demographic trends like growing geriatric population will prove helpful for industry growth. The ageing population base is inclined to chronic neurological disease that elevates the demand for TMS systems. Moreover, the positive regulatory situation for the market will activate the regional transcranial magnetic stimulators market growth. The MMR report covers the segments in the transcranial magnetic stimulation market such as type and application. Based on type, deep transcranial magnetic stimulator (dTMS) segment dominated the transcranial magnetic stimulation market, with market size of US$ xx Mn in 2022 and to reach US$ XX Mn by 2029, with a CAGR of xx.29%. The dTMS is a process that uses magnetic fields created by a coil placed on the scalp. It also permits non-invasive treatment of the area of the deep brain for those suffering from neurological disorders, like depression. By application, the depression segment is dominating the TMS market and valued around US$ XX Mn in 2022. As per the World Health Organization, in 2018, over half of the population diagnosed with depression is getting treatment, like therapies and medication. Also, according to MHA (Mental Health America), around half of the US population has a mental health condition, like MDD (Major Depressive Disorder). Hence, a high incidence of depression globally can attribute to the major market share of the segment. In recent years, major players in the transcranial magnetic stimulators market have taken various strategic measures, such as partnerships and facility expansions. In Sept 2017, eNeura Company received FDA support for eNeura spring transcranial magnetic stimulators, which is designed for the prophylactic and important treatment of migraine. The objective of the report is to present a comprehensive analysis of the Global Transcranial Magnetic Stimulators Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Transcranial Magnetic Stimulators Market dynamics, structure by analyzing the market segments and projects the Global Transcranial Magnetic Stimulators Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Transcranial Magnetic Stimulators Market make the report investor’s guide.
Transcranial Magnetic Stimulators Market Scope : Inquire before buying
Transcranial Magnetic Stimulators Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 1.58 Bn. Forecast Period 2023 to 2029 CAGR: 8.7% Market Size in 2029: US $ 2.83Bn. Segments Covered: by Type • Deep Transcranial Magnetic Stimulator (dTMS) • Repetitive Transcranial Magnetic Stimulator (rTMS) • Others by Application • Alzheimer’s Disease • Depression • Parkinson’s Disease • Epilepsy • Others by Region • North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America) Transcranial Magnetic Stimulators Market Key players
• Axilum Robotics • Mastigm • Nexstim plc • Neuronetics, Inc. • Brainsway Ltd. • TMS Neuro Solutions • Yiruide • Neurosoft • eNeura • MagVenture • Remed • Dr. Langer Medical Frequently Asked Questions: 1. Which region has the largest share in Global Transcranial Magnetic Stimulators Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Transcranial Magnetic Stimulators Market? Ans: The Global Transcranial Magnetic Stimulators Market is growing at a CAGR of 8.7% during forecasting period 2023-2029. 3. What is scope of the Global Transcranial Magnetic Stimulators Market report? Ans: Global Transcranial Magnetic Stimulators Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Transcranial Magnetic Stimulators Market? Ans: The important key players in the Global Transcranial Magnetic Stimulators Market are – Axilum Robotics, Mastigm, Nexstim plc, Neuronetics, Inc., Brainsway Ltd., TMS Neuro Solutions, Yiruide, Neurosoft, eNeura, MagVenture, Remed, and Dr. Langer Medical 5. What is the study period of this Market? Ans: The Global Transcranial Magnetic Stimulators Market is studied from 2022 to 2029.
Global Transcranial Magnetic Stimulators Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Transcranial Magnetic Stimulators Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Transcranial Magnetic Stimulators Market Analysis and Forecast 6.1. Transcranial Magnetic Stimulators Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Transcranial Magnetic Stimulators Market Value Share Analysis, By Type 7.4. Transcranial Magnetic Stimulators Market Size (US$ Bn) Forecast, By Type 7.5. Transcranial Magnetic Stimulators Market Analysis, By Type 7.6. Transcranial Magnetic Stimulators Market Attractiveness Analysis, By Type 8. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Transcranial Magnetic Stimulators Market Value Share Analysis, By Application 8.4. Transcranial Magnetic Stimulators Market Size (US$ Bn) Forecast, By Application 8.5. Transcranial Magnetic Stimulators Market Analysis, By Application 8.6. Transcranial Magnetic Stimulators Market Attractiveness Analysis, By Application 9. Global Transcranial Magnetic Stimulators Market Analysis, by Region 9.1. Transcranial Magnetic Stimulators Market Value Share Analysis, by Region 9.2. Transcranial Magnetic Stimulators Market Size (US$ Bn) Forecast, by Region 9.3. Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Region 10. North America Transcranial Magnetic Stimulators Market Analysis 10.1. Key Findings 10.2. North America Transcranial Magnetic Stimulators Market Overview 10.3. North America Transcranial Magnetic Stimulators Market Value Share Analysis, By Type 10.4. North America Transcranial Magnetic Stimulators Market Forecast, By Type 10.4.1. Deep Transcranial Magnetic Stimulator (dTMS) 10.4.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 10.4.3. Others 10.5. North America Transcranial Magnetic Stimulators Market Value Share Analysis, By Application 10.6. North America Transcranial Magnetic Stimulators Market Forecast, By Application 10.6.1. Alzheimer’s Disease 10.6.2. Depression 10.6.3. Parkinson’s Disease 10.6.4. Epilepsy 10.6.5. Others 10.7. North America Transcranial Magnetic Stimulators Market Value Share Analysis, by Country 10.8. North America Transcranial Magnetic Stimulators Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Transcranial Magnetic Stimulators Market Analysis, by Country 10.10. U.S. Transcranial Magnetic Stimulators Market Forecast, By Type 10.10.1. Deep Transcranial Magnetic Stimulator (dTMS) 10.10.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 10.10.3. Others 10.11. U.S. Transcranial Magnetic Stimulators Market Forecast, By Application 10.11.1. Alzheimer’s Disease 10.11.2. Depression 10.11.3. Parkinson’s Disease 10.11.4. Epilepsy 10.11.5. Others 10.12. Canada Transcranial Magnetic Stimulators Market Forecast, By Type 10.12.1. Deep Transcranial Magnetic Stimulator (dTMS) 10.12.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 10.12.3. Others 10.13. Canada Transcranial Magnetic Stimulators Market Forecast, By Application 10.13.1. Alzheimer’s Disease 10.13.2. Depression 10.13.3. Parkinson’s Disease 10.13.4. Epilepsy 10.13.5. Others 10.14. North America Transcranial Magnetic Stimulators Market Attractiveness Analysis 10.14.1. By Type 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Transcranial Magnetic Stimulators Market Analysis 11.1. Key Findings 11.2. Europe Transcranial Magnetic Stimulators Market Overview 11.3. Europe Transcranial Magnetic Stimulators Market Value Share Analysis, By Type 11.4. Europe Transcranial Magnetic Stimulators Market Forecast, By Type 11.4.1. Deep Transcranial Magnetic Stimulator (dTMS) 11.4.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 11.4.3. Others 11.5. Europe Transcranial Magnetic Stimulators Market Value Share Analysis, By Application 11.6. Europe Transcranial Magnetic Stimulators Market Forecast, By Application 11.6.1. Alzheimer’s Disease 11.6.2. Depression 11.6.3. Parkinson’s Disease 11.6.4. Epilepsy 11.6.5. Others 11.7. Europe Transcranial Magnetic Stimulators Market Value Share Analysis, by Country 11.8. Europe Transcranial Magnetic Stimulators Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Transcranial Magnetic Stimulators Market Analysis, by Country 11.10. Germany Transcranial Magnetic Stimulators Market Forecast, By Type 11.10.1. Deep Transcranial Magnetic Stimulator (dTMS) 11.10.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 11.10.3. Others 11.11. Germany Transcranial Magnetic Stimulators Market Forecast, By Application 11.11.1. Alzheimer’s Disease 11.11.2. Depression 11.11.3. Parkinson’s Disease 11.11.4. Epilepsy 11.11.5. Others 11.12. U.K. Transcranial Magnetic Stimulators Market Forecast, By Type 11.12.1. Deep Transcranial Magnetic Stimulator (dTMS) 11.12.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 11.12.3. Others 11.13. U.K. Transcranial Magnetic Stimulators Market Forecast, By Application 11.13.1. Alzheimer’s Disease 11.13.2. Depression 11.13.3. Parkinson’s Disease 11.13.4. Epilepsy 11.13.5. Others 11.14. France Transcranial Magnetic Stimulators Market Forecast, By Type 11.14.1. Deep Transcranial Magnetic Stimulator (dTMS) 11.14.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 11.14.3. Others 11.15. France Transcranial Magnetic Stimulators Market Forecast, By Application 11.15.1. Alzheimer’s Disease 11.15.2. Depression 11.15.3. Parkinson’s Disease 11.15.4. Epilepsy 11.15.5. Others 11.16. Italy Transcranial Magnetic Stimulators Market Forecast, By Type 11.16.1. Deep Transcranial Magnetic Stimulator (dTMS) 11.16.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 11.16.3. Others 11.17. Italy Transcranial Magnetic Stimulators Market Forecast, By Application 11.17.1. Alzheimer’s Disease 11.17.2. Depression 11.17.3. Parkinson’s Disease 11.17.4. Epilepsy 11.17.5. Others 11.18. Spain Transcranial Magnetic Stimulators Market Forecast, By Type 11.18.1. Deep Transcranial Magnetic Stimulator (dTMS) 11.18.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 11.18.3. Others 11.19. Spain Transcranial Magnetic Stimulators Market Forecast, By Application 11.19.1. Alzheimer’s Disease 11.19.2. Depression 11.19.3. Parkinson’s Disease 11.19.4. Epilepsy 11.19.5. Others 11.20. Rest of Europe Transcranial Magnetic Stimulators Market Forecast, By Type 11.20.1. Deep Transcranial Magnetic Stimulator (dTMS) 11.20.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 11.20.3. Others 11.21. Rest of Europe Transcranial Magnetic Stimulators Market Forecast, By Application 11.21.1. Alzheimer’s Disease 11.21.2. Depression 11.21.3. Parkinson’s Disease 11.21.4. Epilepsy 11.21.5. Others 11.22. Europe Transcranial Magnetic Stimulators Market Attractiveness Analysis 11.22.1. By Type 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Transcranial Magnetic Stimulators Market Analysis 12.1. Key Findings 12.2. Asia Pacific Transcranial Magnetic Stimulators Market Overview 12.3. Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, By Type 12.4. Asia Pacific Transcranial Magnetic Stimulators Market Forecast, By Type 12.4.1. Deep Transcranial Magnetic Stimulator (dTMS) 12.4.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 12.4.3. Others 12.5. Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, By Application 12.6. Asia Pacific Transcranial Magnetic Stimulators Market Forecast, By Application 12.6.1. Alzheimer’s Disease 12.6.2. Depression 12.6.3. Parkinson’s Disease 12.6.4. Epilepsy 12.6.5. Others 12.7. Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, by Country 12.8. Asia Pacific Transcranial Magnetic Stimulators Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Transcranial Magnetic Stimulators Market Analysis, by Country 12.10. China Transcranial Magnetic Stimulators Market Forecast, By Type 12.10.1. Deep Transcranial Magnetic Stimulator (dTMS) 12.10.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 12.10.3. Others 12.11. China Transcranial Magnetic Stimulators Market Forecast, By Application 12.11.1. Alzheimer’s Disease 12.11.2. Depression 12.11.3. Parkinson’s Disease 12.11.4. Epilepsy 12.11.5. Others 12.12. India Transcranial Magnetic Stimulators Market Forecast, By Type 12.12.1. Deep Transcranial Magnetic Stimulator (dTMS) 12.12.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 12.12.3. Others 12.13. India Transcranial Magnetic Stimulators Market Forecast, By Application 12.13.1. Alzheimer’s Disease 12.13.2. Depression 12.13.3. Parkinson’s Disease 12.13.4. Epilepsy 12.13.5. Others 12.14. Japan Transcranial Magnetic Stimulators Market Forecast, By Type 12.14.1. Deep Transcranial Magnetic Stimulator (dTMS) 12.14.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 12.14.3. Others 12.15. Japan Transcranial Magnetic Stimulators Market Forecast, By Application 12.15.1. Alzheimer’s Disease 12.15.2. Depression 12.15.3. Parkinson’s Disease 12.15.4. Epilepsy 12.15.5. Others 12.16. ASEAN Transcranial Magnetic Stimulators Market Forecast, By Type 12.16.1. Deep Transcranial Magnetic Stimulator (dTMS) 12.16.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 12.16.3. Others 12.17. ASEAN Transcranial Magnetic Stimulators Market Forecast, By Application 12.17.1. Alzheimer’s Disease 12.17.2. Depression 12.17.3. Parkinson’s Disease 12.17.4. Epilepsy 12.17.5. Others 12.18. Rest of Asia Pacific Transcranial Magnetic Stimulators Market Forecast, By Type 12.18.1. Deep Transcranial Magnetic Stimulator (dTMS) 12.18.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 12.18.3. Others 12.19. Rest of Asia Pacific Transcranial Magnetic Stimulators Market Forecast, By Application 12.19.1. Alzheimer’s Disease 12.19.2. Depression 12.19.3. Parkinson’s Disease 12.19.4. Epilepsy 12.19.5. Others 12.20. Asia Pacific Transcranial Magnetic Stimulators Market Attractiveness Analysis 12.20.1. By Type 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Transcranial Magnetic Stimulators Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Transcranial Magnetic Stimulators Market Overview 13.3. Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, By Type 13.4. Middle East & Africa Transcranial Magnetic Stimulators Market Forecast, By Type 13.4.1. Deep Transcranial Magnetic Stimulator (dTMS) 13.4.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 13.4.3. Others 13.5. Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, By Application 13.6. Middle East & Africa Transcranial Magnetic Stimulators Market Forecast, By Application 13.6.1. Alzheimer’s Disease 13.6.2. Depression 13.6.3. Parkinson’s Disease 13.6.4. Epilepsy 13.6.5. Others 13.7. Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, by Country 13.8. Middle East & Africa Transcranial Magnetic Stimulators Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Transcranial Magnetic Stimulators Market Analysis, by Country 13.10. GCC Transcranial Magnetic Stimulators Market Forecast, By Type 13.10.1. Deep Transcranial Magnetic Stimulator (dTMS) 13.10.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 13.10.3. Others 13.11. GCC Transcranial Magnetic Stimulators Market Forecast, By Application 13.11.1. Alzheimer’s Disease 13.11.2. Depression 13.11.3. Parkinson’s Disease 13.11.4. Epilepsy 13.11.5. Others 13.12. South Africa Transcranial Magnetic Stimulators Market Forecast, By Type 13.12.1. Deep Transcranial Magnetic Stimulator (dTMS) 13.12.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 13.12.3. Others 13.13. South Africa Transcranial Magnetic Stimulators Market Forecast, By Application 13.13.1. Alzheimer’s Disease 13.13.2. Depression 13.13.3. Parkinson’s Disease 13.13.4. Epilepsy 13.13.5. Others 13.14. Rest of Middle East & Africa Transcranial Magnetic Stimulators Market Forecast, By Type 13.14.1. Deep Transcranial Magnetic Stimulator (dTMS) 13.14.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 13.14.3. Others 13.15. Rest of Middle East & Africa Transcranial Magnetic Stimulators Market Forecast, By Application 13.15.1. Alzheimer’s Disease 13.15.2. Depression 13.15.3. Parkinson’s Disease 13.15.4. Epilepsy 13.15.5. Others 13.16. Middle East & Africa Transcranial Magnetic Stimulators Market Attractiveness Analysis 13.16.1. By Type 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Transcranial Magnetic Stimulators Market Analysis 14.1. Key Findings 14.2. South America Transcranial Magnetic Stimulators Market Overview 14.3. South America Transcranial Magnetic Stimulators Market Value Share Analysis, By Type 14.4. South America Transcranial Magnetic Stimulators Market Forecast, By Type 14.4.1. Deep Transcranial Magnetic Stimulator (dTMS) 14.4.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 14.4.3. Others 14.5. South America Transcranial Magnetic Stimulators Market Value Share Analysis, By Application 14.6. South America Transcranial Magnetic Stimulators Market Forecast, By Application 14.6.1. Alzheimer’s Disease 14.6.2. Depression 14.6.3. Parkinson’s Disease 14.6.4. Epilepsy 14.6.5. Others 14.7. South America Transcranial Magnetic Stimulators Market Value Share Analysis, by Country 14.8. South America Transcranial Magnetic Stimulators Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Transcranial Magnetic Stimulators Market Analysis, by Country 14.10. Brazil Transcranial Magnetic Stimulators Market Forecast, By Type 14.10.1. Deep Transcranial Magnetic Stimulator (dTMS) 14.10.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 14.10.3. Others 14.11. Brazil Transcranial Magnetic Stimulators Market Forecast, By Application 14.11.1. Alzheimer’s Disease 14.11.2. Depression 14.11.3. Parkinson’s Disease 14.11.4. Epilepsy 14.11.5. Others 14.12. Mexico Transcranial Magnetic Stimulators Market Forecast, By Type 14.12.1. Deep Transcranial Magnetic Stimulator (dTMS) 14.12.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 14.12.3. Others 14.13. Mexico Transcranial Magnetic Stimulators Market Forecast, By Application 14.13.1. Alzheimer’s Disease 14.13.2. Depression 14.13.3. Parkinson’s Disease 14.13.4. Epilepsy 14.13.5. Others 14.14. Rest of South America Transcranial Magnetic Stimulators Market Forecast, By Type 14.14.1. Deep Transcranial Magnetic Stimulator (dTMS) 14.14.2. Repetitive Transcranial Magnetic Stimulator (rTMS) 14.14.3. Others 14.15. Rest of South America Transcranial Magnetic Stimulators Market Forecast, By Application 14.15.1. Alzheimer’s Disease 14.15.2. Depression 14.15.3. Parkinson’s Disease 14.15.4. Epilepsy 14.15.5. Others 14.16. South America Transcranial Magnetic Stimulators Market Attractiveness Analysis 14.16.1. By Type 14.16.2. By Application 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Vehicles 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Axilum Robotics 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Mastigm 15.3.3. Nexstim plc 15.3.4. Neuronetics, Inc. 15.3.5. Brainsway Ltd. 15.3.6. TMS Neuro Solutions 15.3.7. Yiruide 15.3.8. Neurosoft 15.3.9. eNeura 15.3.10. MagVenture 15.3.11. Remed 15.3.12. Dr. Langer Medical 16. Primary Key Insights